Search research articles
Contact Us
Filters
Showing results (91-100 of 153) with videos related to
Page
of 16
Sort By:
European Urology
|
July 20, 2017
Recommendations for the Management of Rare Kidney Cancers
Rachel H Giles, Toni K Choueiri, Daniel Y Heng, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
The Lancet. Oncology
|
August 11, 2012
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
Lauren C Harshman, Wanling Xie, Georg A Bjarnason, et al.
Clinical Genitourinary Cancer
|
February 4, 2014
A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma
Nimira Alimohamed, Jae-Lyn Lee, Sandy Srinivas, et al.
Circulation
|
June 28, 2022
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis
Han Zhu, Francisco X Galdos, Daniel Lee, et al.
JAMA Oncology
|
August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial
Sumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Clinical Genitourinary Cancer
|
November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population
Andrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
European Urology
|
August 22, 2013
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
Rana R McKay, Nils Kroeger, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 153) with videos related to
Sort By:
Page
of 16
European Urology
|
July 20, 2017
Recommendations for the Management of Rare Kidney Cancers
Rachel H Giles, Toni K Choueiri, Daniel Y Heng, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
The Lancet. Oncology
|
August 11, 2012
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
Lauren C Harshman, Wanling Xie, Georg A Bjarnason, et al.
Clinical Genitourinary Cancer
|
February 4, 2014
A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma
Nimira Alimohamed, Jae-Lyn Lee, Sandy Srinivas, et al.
Circulation
|
June 28, 2022
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis
Han Zhu, Francisco X Galdos, Daniel Lee, et al.
JAMA Oncology
|
August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial
Sumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Clinical Genitourinary Cancer
|
November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population
Andrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
European Urology
|
August 22, 2013
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
Rana R McKay, Nils Kroeger, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Page
of 16